Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

MGUS Prevalence in Special Populations: Insights from a Large-Scale Community Study from Rural India (IMAGe-002B Study)

Uday Yanamandra, Harikrishnan Premdeep, J Muthukrishnan, Narendra Kotwal, Pankaj Malhotra, Velu Nair, Shaji Kumar

Blood (2024) 144 (Supplement 1): 1916.

https://doi.org/10.1182/blood-2024-210555

Published: 2024

Journal Articles

Impact of Consolidation Radiotherapy in Bulky Diffuse Large B Cell Lymphoma By PET Based Response Assessment

Blood (2024) 144 (Supplement 1): 3078.

https://doi.org/10.1182/blood-2024-203645

Published: 2024

Journal Articles

Fertility and Parenthood in Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide and All-Trans Retinoic Acid

Charanpreet Singh, Manpreet Saini, Arihant Jain, Deepesh Pravinkumar Lad, Gaurav Prakash, Alka Rani Khadwal, Shano Naseem, Pankaj Malhotra

Blood (2023) 142 (Supplement 1): 5177.

https://doi.org/10.1182/blood-2023-181422

Published: 2023

Journal Articles

Primary Analysis of Varnimcabtagene Autoleucel (IMN-003A) in Phase 2 Study (IMAGINE), a First-in-India Industry CD19-Directed CAR-T Cell Therapy for Patients with Relapsed Refractory B Cell Malignancies

Blood (2023) 142 (Supplement 1): 2104.

https://doi.org/10.1182/blood-2023-179424

Published: 2023

Journal Articles

Successful Treatment-Free Remission in Low- and Middle-Income Countries

Jerald P. Radich, Ines Garcia Gonzalez, Alicia Annamalay, Geoff Cook, Isaac Jenkins, Flora Duarte, VP Gangadharan, Hemant Malhotra, Pankaj Malhotra, Karen Meliksetyan, Rafael Zuniga, Nicholas Anthony Othieno-Abinja, Jose Zarza, Pat Garcia-Gonzalez

Blood (2023) 142 (Supplement 1): 1808.

https://doi.org/10.1182/blood-2023-191049

Published: 2023

Journal Articles

Correlation of Flow Cytometric BCL2 and MCL1 Expression with Cytogenetic Characteristics and Outcome in Multiple Myeloma

Shelly Singla, Sreejesh Sreedharanunni, Archana Singh, Anand Balakrishnan, Anshu Anshu, Shailja Rathore, Parveen Bose, Man Updesh Singh Sachdeva, Praveen Sharma, Nabhajit Mallik, Reena Das, Deepesh Pravinkumar Lad, Pankaj Malhotra

Blood (2023) 142 (Supplement 1): 6581.

https://doi.org/10.1182/blood-2023-185707

Published: 2023

Journal Articles

Albumin: Globulin Reversal As a Screening Tool for Monoclonal Gammopathy (Targeted Screening) in Hospitalized Setting

Celine Raphael, Uday Yanamandra, Abhinav Kumar, Narendra Kotwal, Pankaj Malhotra, Velu Nair

Blood (2023) 142 (Supplement 1): 6761.

https://doi.org/10.1182/blood-2023-191309

Published: 2023

Journal Articles

The Bengaluru Score - a Prognostic Predictive Score for Clinical Efficacy Outcomes Based on Discovery Cohort of Patients Treated with Varnimcabtagene Autoleucel (IMN-003A) in the Phase-2 (IMAGINE) Study

Anil Kamat, Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Pallavi Arasu, Mohammed Manzoor Akheel, Arun Anand

Blood (2023) 142 (Supplement 1): 6859.

https://doi.org/10.1182/blood-2023-181120

Published: 2023

Journal Articles

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

Blood (2023) 142 (Supplement 1): 6876.

https://doi.org/10.1182/blood-2023-179709

Published: 2023

Journal Articles

Modified Endothelial Activation and Stress Index (mEASIX) Score and Immune Effector Cell Associated Haematotoxicity (ICAHT) Following Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Sunil Bhat, Sharat Damodar, Raja Thirumalairaj, Pankaj Malhotra, Pooja Mallya, Akshatha Nayak, Ravi Joshi, Revathy Raj, Charanpreet Singh, Rameez Ahamed, Manjunatha BR, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat

Blood (2023) 142 (Supplement 1): 6856.

https://doi.org/10.1182/blood-2023-180478

Published: 2023

Journal Articles

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Sudeshna Dhar, Sandeepa Shetty, Mani Bharathi T.I., Anne Roshan Joseph, Gowri Shankar Krishnan, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Rahul Nahar, Lakshmikanth Gandikota, Anil Kamat

Blood (2023) 142 (Supplement 1): 6862.

https://doi.org/10.1182/blood-2023-181585

Published: 2023

Journal Articles

Prevalence of MGUS in Rural Indian Population: Results of Simple (IMAGe-002A) Study

Celine Raphael, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair

Blood (2023) 142 (Supplement 1): 6755.

https://doi.org/10.1182/blood-2023-189661

Published: 2023

Journal Articles

Normative Data of Beta-2-Microglobulin and Plasma Proteins from an Agrarian Indian Community By a Door-to-Door Survey: Results of Simple (IMAGe-002B) Study

Yash Vashishth, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair

Blood (2023) 142 (Supplement 1): 6760.

https://doi.org/10.1182/blood-2023-191125

Published: 2023

Journal Articles

Factors Associated with Refractoriness or Relapse after Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies: Phase 2 First-in-India Industry (IMAGINE) Study

Blood (2023) 142 (Supplement 1): 6879.

https://doi.org/10.1182/blood-2023-181112

Published: 2023

Journal Articles

Association between Heavy Metal Exposure and Idiopathic Aplastic Anemia in Adolescents and Adults:a Case Control Study from Northern India

Arihant Jain, Sarthak Wadhera, Pankaj Malhotra, Charanpreet Singh, Deepesh Pravinkumar Lad, Alka Rani Khadwal, Gaurav Prakash, Neelam Varma, Prabhakar Reddy

Blood (2023) 142 (Supplement 1): 7323.

https://doi.org/10.1182/blood-2023-191172

Published: 2023

Journal Articles

Hypogammaglobulinemia and Infection Risk in Relapsed Refractory B Cell Malignancy Patients Treated with Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Akshatha Nayak, Pooja Mallya, Ravi Joshi, Revathy Raj, Rameez Ahamed, Charanpreet Singh, Raja B, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat

Blood (2023) 142 (Supplement 1): 6853.

https://doi.org/10.1182/blood-2023-179833

Published: 2023

Journal Articles

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

Blood (2023) 142 (Supplement 1): 6881.

https://doi.org/10.1182/blood-2023-184521

Published: 2023

Journal Articles

Long-Term Real-World Outcomes of Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide and All Trans Retinoic Acid without Chemotherapy

Charanpreet Singh, Uday Yanamandra, Parathan Karunakaran, Nishant Jindal, Saloni Rani Kumar, Neha Saini, Aditya Jandial, Arihant Jain, Chandan Das, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Shano Naseem, Reena Das, Neelam Varma, Subhash Varma, Pankaj Malhotra

Blood (2022) 140 (Supplement 1): 8108–8110.

https://doi.org/10.1182/blood-2022-164611

Published: 2022

Journal Articles

Study of JAK2 V617F allele Burden By Droplet Digital PCR in BCR-ABL1 Negative Myeloproliferative Neoplasms and Its Implications on Disease Phenotype

Loomila L, Shano Naseem, Pulkit Rastogi, Arihant Jain, Pankaj Malhotra

Blood (2022) 140 (Supplement 1): 12270.

https://doi.org/10.1182/blood-2022-168835

Published: 2022

Journal Articles

Comparable Long-Term Outcomes of Low-Dose Versus Standard-Dose Equine Anti-Thymocyte Globulin with Cyclosporine in Aplastic Anemia

Aditya Jandial, Charanpreet Singh, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Reena Das, Neelam Varma, Subhash Varma, Pankaj Malhotra, Arihant Jain

Blood (2022) 140 (Supplement 1): 1221–1222.

https://doi.org/10.1182/blood-2022-169080

Published: 2022

NARROW

MGUS Prevalence in Special Populations: Insights from a Large-Scale Community Study from Rural India (IMAGe-002B Study)

Impact of Consolidation Radiotherapy in Bulky Diffuse Large B Cell Lymphoma By PET Based Response Assessment

Fertility and Parenthood in Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide and All-Trans Retinoic Acid

Primary Analysis of Varnimcabtagene Autoleucel (IMN-003A) in Phase 2 Study (IMAGINE), a First-in-India Industry CD19-Directed CAR-T Cell Therapy for Patients with Relapsed Refractory B Cell Malignancies

Successful Treatment-Free Remission in Low- and Middle-Income Countries

Correlation of Flow Cytometric BCL2 and MCL1 Expression with Cytogenetic Characteristics and Outcome in Multiple Myeloma

Albumin: Globulin Reversal As a Screening Tool for Monoclonal Gammopathy (Targeted Screening) in Hospitalized Setting

The Bengaluru Score - a Prognostic Predictive Score for Clinical Efficacy Outcomes Based on Discovery Cohort of Patients Treated with Varnimcabtagene Autoleucel (IMN-003A) in the Phase-2 (IMAGINE) Study

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

Modified Endothelial Activation and Stress Index (mEASIX) Score and Immune Effector Cell Associated Haematotoxicity (ICAHT) Following Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

Prevalence of MGUS in Rural Indian Population: Results of Simple (IMAGe-002A) Study

Normative Data of Beta-2-Microglobulin and Plasma Proteins from an Agrarian Indian Community By a Door-to-Door Survey: Results of Simple (IMAGe-002B) Study

Factors Associated with Refractoriness or Relapse after Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies: Phase 2 First-in-India Industry (IMAGINE) Study

Association between Heavy Metal Exposure and Idiopathic Aplastic Anemia in Adolescents and Adults:a Case Control Study from Northern India

Hypogammaglobulinemia and Infection Risk in Relapsed Refractory B Cell Malignancy Patients Treated with Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

Long-Term Real-World Outcomes of Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide and All Trans Retinoic Acid without Chemotherapy

Study of JAK2 V617F allele Burden By Droplet Digital PCR in BCR-ABL1 Negative Myeloproliferative Neoplasms and Its Implications on Disease Phenotype

Comparable Long-Term Outcomes of Low-Dose Versus Standard-Dose Equine Anti-Thymocyte Globulin with Cyclosporine in Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only